Participate in Our Trials

Want to be involved in a research project that will make a difference?

Our members manage research projects, clinical trials and cohort studies that require volunteers. If you'd like to be involved in any of the projects below, contact the relevant research team.

If these projects aren't relevant to you, check back on this list; new projects are uploaded regularly.

    Expand
  • COVALIA COVID Vaccine Study

    Participants required for COVID-19 vaccine trial

    The Vaccinology and Immunology Research Trials Unit (VIRTU) is partnering with researchers interstate on a new study which aims to evaluate the safety and tolerability of a new investigational DNA vaccine, COVIGEN, which is being developed to protect against SARS CoV-2 virus.

    Known as the COVALIA study, it will be the first time the vaccine is trialled in humans and researchers are seeking a total of 150 participants across Sydney, Adelaide and Perth. 

    Eligible participants must be:

    • A healthy male or healthy female who is not pregnant or who cannot bear children
    •  Aged 18-75 (inclusive)
    • Non-smoker
    • Have no history of alcohol or drug abuse.

    Each participant will receive two doses of the study vaccine or placebo 28 days apart.

    The vaccine will be administered either intradermally or intramuscularly (depending on which vaccine group you are randomised to) via needle-free high-pressure jet technology.

    The study will require 8 visits to the hospital and two phone calls over a period of 12 months. Participants will be reimbursed for their time and inconvenience.

    COVALIA has been approved by the Women’s and Children’s Health Network’s Human Research Ethics Committee.

    For further information about the COVALIA study contact Meredith Krieg, Research Nurse (VIRTU) on 8161 7349 or on 8161 6328, or at VIRTU@adelaide.edu.au.

  • Is your child allergic to peanut?

    Is your child aged between 1 and 10 years of age?

    The Women's and Children's Hospital is conducting a study evaluating a possible new treatment for peanut allergy.

    To find out more, please contact:

    The Research Team
    Department Allergy and Clinical Immunology
    Women's and Children's Hospital
    8161 9294 or Health.CYWHSAllergyResearch@sa.gov.au.

  • Meningococcal B vaccine study for toddlers

    The Vaccinology and Immunology Research Trials Unit (VIRTU) at the Women’s and Children’s Hospital are conducting a study to evaluate the safety, tolerability and immune response of a potential vaccine  against meningococcal B disease.

    Meningococcal disease is a severe and rapid-onset infection which can result in death within hours, due to septicaemia (blood poisoning) or meningitis (inflammation of the membrane lining of the brain and spinal cord). The meningococcus bacteria is carried, usually harmlessly, in the nose and throat of around 10% of the population (‘carriers’), with higher carriage in some specific groups. The bacteria are passed from person-to-person by close prolonged contact with fine droplets spread by coughing, sneezing and spluttering. However, only a very small number of people in close contact with carriers develop meningococcal disease. Even though it is hard to catch and uncommon, meningococcal disease can be a serious illness for those who are infected.

    Participants will need to visit the Women’s and Children’s Hospital 8 times over an 18-month period and some participants will be asked to do further follow-up with yearly blood draws for 3 years longer. Study vaccines will be provided at no cost and you will be provided with a voucher for your travel expenses.

    We are seeking healthy toddlers 18 months to less than 24 months of age to take part in this meningococcal B vaccine study.

    To register your interest or for more information, contact VIRTU at the Women’s and Children’s Hospital on (08) 8161 8117.

    This study has been approved by the Women’s and Children’s Health Network Human Ethics Committee.

  • Uncovering the causes of cerebral palsy study

    Approximately 1 in every 500 children is born with cerebral palsy.

    It is now recognised that most cases are associated with factors present before labour begins, and not as a result of events which occur during labour and delivery.

    What actually causes cerebral palsy is not clear. In order to determine these factors, it is important to conduct research into the possible causes of cerebral palsy.

    The Australian Collaborative Cerebral Palsy Research Group

  • ENDIA study: Why are more children getting type 1 diabetes?

    Type 1 diabetes in children is twice as common as it was 20 years ago. This is because the environment has changed and this has made it more likely that children will develop type 1 diabetes.

    If we can understand what factors in the environment are harmful or protective, and how they interact with our genes, we can modify the environment to try to prevent type 1 diabetes.

    The ENDIA study is Australia's biggest type 1 diabetes study and is aiming to recruite 1,400 people to discover the environmental triggers for this disease.

    The ENDIA study